U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.581G>A (p.Trp194Ter) AND Hereditary cancer-predisposing syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 20, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002354232.9

Allele description [Variation Report for NM_000059.4(BRCA2):c.581G>A (p.Trp194Ter)]

NM_000059.4(BRCA2):c.581G>A (p.Trp194Ter)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.581G>A (p.Trp194Ter)
HGVS:
  • NC_000013.11:g.32326563G>A
  • NG_012772.3:g.16084G>A
  • NM_000059.4:c.581G>AMANE SELECT
  • NP_000050.2:p.Trp194Ter
  • NP_000050.3:p.Trp194Ter
  • LRG_293t1:c.581G>A
  • LRG_293:g.16084G>A
  • LRG_293p1:p.Trp194Ter
  • NC_000013.10:g.32900700G>A
  • NM_000059.3:c.581G>A
  • U43746.1:n.809G>A
  • p.Trp194*
Nucleotide change:
809G>A
Protein change:
W194*
Links:
dbSNP: rs80358809
NCBI 1000 Genomes Browser:
rs80358809
Molecular consequence:
  • NM_000059.4:c.581G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002650781Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Feb 20, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay.

Biswas K, Das R, Alter BP, Kuznetsov SG, Stauffer S, North SL, Burkett S, Brody LC, Meyer S, Byrd RA, Sharan SK.

Blood. 2011 Sep 1;118(9):2430-42. doi: 10.1182/blood-2010-12-324541. Epub 2011 Jun 30.

PubMed [citation]
PMID:
21719596
PMCID:
PMC3167357

Functional analysis of a large set of BRCA2 exon 7 variants highlights the predictive value of hexamer scores in detecting alterations of exonic splicing regulatory elements.

Di Giacomo D, Gaildrat P, Abuli A, Abdat J, Frébourg T, Tosi M, Martins A.

Hum Mutat. 2013 Nov;34(11):1547-57. doi: 10.1002/humu.22428. Epub 2013 Sep 18.

PubMed [citation]
PMID:
23983145
See all PubMed Citations (3)

Details of each submission

From Ambry Genetics, SCV002650781.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The p.W194* pathogenic mutation (also known as c.581G>A), located in coding exon 6 of the BRCA2 gene, results from a G to A substitution at nucleotide position 581. This changes the amino acid from a tryptophan to a stop codon within coding exon 6. This alteration has been detected in a familial breast cancer kindred and shown increase exon skipping in vitro (Couch FJ et al. Nat. Genet., 1996 May;13:123-5; Di Giacomo D et al. Hum. Mutat., 2013 Nov;34:1547-57; Biswas K et al. Blood, 2011 Sep;118:2430-42). Of note, this alteration is also known as 809G>A and Trp194X in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 25, 2024